LENZ Therapeutics (LENZ) Depreciation and Depletion (2020 - 2023)
LENZ Therapeutics (LENZ) reported Depreciation and Depletion of $100000.0 for Q4 2023, down 85.71% year-over-year from $700000.0 in Q4 2022, and down 87.5% quarter-over-quarter from $800000.0 in Q3 2023.
LENZ Therapeutics (LENZ) Depreciation and Depletion (2020 - 2023) Analysis & Trends
LENZ Therapeutics (LENZ) has 4 years of Depreciation and Depletion data on file, last reported at $100000.0 in Q4 2023.
- Depreciation and Depletion for Q4 2023 came in at $100000.0, down 85.71% year-over-year; the trailing twelve-month figure through Dec 2023 was $2.4 million (changed 0.0% YoY), and the FY2023 annual result was $2.4 million, changed 0.0% from the prior year.
- Depreciation and Depletion declined to $100000.0 in Q4 2023 per LENZ's latest filing, from $800000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $800000.0 in Q2 2023 and troughed at $1000.0 in Q2 2020.
- A 4-year average of $400071.4 and a median of $350000.0 in 2021 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2021 and 2023: Depreciation and Depletion surged 9900.0% in 2021, then plunged 85.71% in 2023.
- A 4-year view of Depreciation and Depletion shows it stood at $100000.0 in 2020, then jumped by 200.0% to $300000.0 in 2021, then surged by 133.33% to $700000.0 in 2022, then plunged by 85.71% to $100000.0 in 2023.
- Business Quant data shows LENZ's Depreciation and Depletion at $100000.0 in Q4 2023, $800000.0 in Q3 2023, and $800000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | LENZ Therapeutics | 192.19 Mn | 192.19 Mn | 825,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 800,000.00 |
| Sep 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 800,000.00 |
| Mar 31, 2023 | 700,000.00 |
| Mar 31, 2023 | 700,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Dec 31, 2022 | 700,000.00 |
| Sep 30, 2022 | 700,000.00 |
| Sep 30, 2022 | 700,000.00 |
| Jun 30, 2022 | 600,000.00 |
| Jun 30, 2022 | 600,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Mar 31, 2022 | 400,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Sep 30, 2021 | 200,000.00 |